Skip to content

Dermatology and cosmetics

Dermatology and cosmetics

Molecular evidence for dermo-cosmetic actives, from skin biology to the claims a study can support.

8
analyses
5
questions
2
programs

Programs

Our programs

Xplorer™ program

Skin Biology Xplorer™

Support your product claims with molecular evidence. Includes Cosmetics 360.

  • 2D cells, reconstructed 3D skin and human explants
  • Transcriptomics, proteomics and metabolomics
  • A claims–evidence matrix, claim by claim
3
model levels
4
questions
8
application areas

360 offer

Cosmetics 360

From biological mechanism to proof of efficacy, for cosmetic actives and finished products.

  • Extracellular vesicles and exosomes, telomeres, senescence, skin microbiome
  • Three packages: Essential, Advanced, 360
  • Part of Skin Biology Xplorer™
3
packages
4
areas of measurement
1
contract

Questions

What a study has to answer

Five questions a dermo-cosmetic study has to settle, measured on cells, explants or 3D models.

The questions we take on

  1. Does the active measurably change skin biology, and by how much?
  2. Which biological processes does it affect, and do the transcriptomic, proteomic and metabolomic signals converge on the same answer?
  3. Does the response extend beyond the cells themselves, through the microbiome or through vesicle signaling?
  4. Is the effect reproducible across donors, or driven by one or two of them?
  5. Do formulation iterations produce genuinely different biological signatures, and can the difference be attributed to the change you made?
Illustrated case studySkin Biology Xplorer™
Selected effects of the extractExtract vs vehicle, UV-exposed models (illustrative)TranscriptomicsProteomicsMetabolomicsPhenotypic testDermal matrixCOL1A1 mRNA×1.6COL3A1 mRNA×1.4MMP1 mRNA×0.55Collagen I α1 protein+22%Decorin protein+15%MMP-1 protein−31%Oxidative stressGSH/GSSG ratio×1.4SenescenceSA-β-gal+ fibroblasts−28%Energy metabolismNAD⁺/NADH ratio (in vitro)×1.3−400+40+80Change vs vehicle (%)Illustrative results. Fold changes are shown as percentage change (×1.6 = +60%).Selected effects of the extractExtract vs vehicle,UV-exposed models (illustrative)TranscriptomicsProteomicsMetabolomicsPhenotypic testDermal matrixCOL1A1 mRNA×1.6COL3A1 mRNA×1.4MMP1 mRNA×0.55Collagen I α1 protein+22%Decorin protein+15%MMP-1 protein−31%Oxidative stressGSH/GSSG ratio×1.4SenescenceSA-β-gal+ fibroblasts−28%Energy metabolismNAD⁺/NADH ratio (in vitro)×1.3−400+40+80Change vs vehicle (%)Illustrative results. Fold changes are shown aspercentage change (×1.6 = +60%).
Key result · Claims: 4 supported · 2 supported with restricted wording · 1 not supported. Mechanism: NRF2 antioxidant response + reduced senescence secretome + dermal-matrix preservation, with a non-retinoid molecular profile. Illustrative results Read the case study

How a study runs

From data to biological evidence

  1. 01

    Question and design

    How many donors and how many replicates are needed before an effect can be told apart from donor variability at all: that question has to be settled before sampling, not after. A study that cannot separate the two will produce data, but not evidence.

  2. 02

    Samples

    The matrix sets the protocol. Accepted sample types are listed under Samples we accept, below.

  3. 03

    Laboratory measurement

    The molecular evidence behind efficacy claims and mechanism-of-action studies is measured in our Marseille laboratories, on models from partner CROs where the study needs them.

  4. 04

    Interpretation

    Where several layers are available, we integrate them to find converging signals, separate robust effects from technical or donor variability, and build the evidence around the claim.

  5. 05

    Deliverables

    The report, the data tables and the claims–evidence matrix.

    What you receive →

Sample requirements, logistics and turnaround are defined per study.

The analysis does not have to start there. Transcriptomics, proteomics, metabolomics, microbiome or extracellular-vesicle data from an earlier study, an internal program or another provider can be analyzed on its own terms. What determines the analysis is the biological question, the study design and the metadata available.

Analysis

What the analysis covers

Transcriptomic profiling
Differential expression between treated and untreated conditions, at gene and pathway level, with effect sizes and significance reported per comparison.
Proteomic profiling
Protein-level quantification and differential abundance, matched against the transcriptomic result. Targeted panels where a candidate needs confirmation.
Extracellular vesicle profiling
Vesicle isolation, size distribution and particle count, with molecular cargo profiled alongside the cells that released it. For actives that act on cell-to-cell communication rather than through a single intracellular pathway.
Microbiome profiling
Skin community composition before and after treatment, where the claim involves the microbiome.
Cross-omics integration
Layers measured on the same samples and read together, so a signal seen in several of them carries more weight than one seen in a single measurement.
Reporting
Tool versions, parameters and thresholds for every step. QC per sample and per cohort, with exclusions stated and justified. Interpretation written against the question the study started from, stating what the data support and what they do not. Processed matrices, result tables, versioned pipelines and figures, delivered for audit or reproduction by a third party.

Samples we accept

Ex vivo skin explants, biopsies, swabs, tape strips and culture supernatant. Collection and storage protocols, and the RNA criteria that apply after extraction, are published per sample type.

Where the bench stops

A platform order delivers primary data. Alignment, quantification, integration and modeling are run by our computational team within Skin Biology Xplorer™: ask for it in the quote request and both are scoped together. For the complete offer, see Cosmetics 360.

Have a project in this space?

Tell us the active, the design and the claim you need to support.